News stories about PerkinElmer (NYSE:PKI) have been trending positive on Saturday, according to Accern. The research firm identifies positive and negative news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. PerkinElmer earned a daily sentiment score of 0.26 on Accern’s scale. Accern also assigned media coverage about the medical research company an impact score of 46.1424187206453 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Here are some of the news articles that may have impacted Accern’s rankings:
PerkinElmer (PKI) traded up $0.92 during midday trading on Friday, hitting $71.03. 739,669 shares of the company traded hands, compared to its average volume of 605,188. The company has a current ratio of 2.59, a quick ratio of 2.09 and a debt-to-equity ratio of 0.44. The company has a market cap of $7,727.89, a P/E ratio of 25.22, a P/E/G ratio of 2.10 and a beta of 0.77. PerkinElmer has a fifty-two week low of $50.59 and a fifty-two week high of $74.11.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Friday, January 19th will be issued a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 0.39%. The ex-dividend date of this dividend is Thursday, January 18th. PerkinElmer’s dividend payout ratio is currently 7.78%.
Several analysts have commented on PKI shares. Robert W. Baird boosted their target price on shares of PerkinElmer from $75.00 to $78.00 and gave the stock an “outperform” rating in a research report on Friday, November 3rd. Morgan Stanley boosted their target price on shares of PerkinElmer from $77.00 to $78.00 and gave the stock an “overweight” rating in a research report on Friday, November 3rd. Jefferies Group reissued a “hold” rating and issued a $70.00 target price on shares of PerkinElmer in a research report on Friday, October 20th. Goldman Sachs Group reissued a “neutral” rating and issued a $67.00 target price on shares of PerkinElmer in a research report on Tuesday, September 26th. Finally, ValuEngine downgraded shares of PerkinElmer from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and six have given a buy rating to the company. PerkinElmer presently has an average rating of “Hold” and a consensus price target of $68.64.
In related news, Director Alexis P. Michas sold 5,000 shares of the company’s stock in a transaction on Thursday, November 30th. The shares were sold at an average price of $73.18, for a total transaction of $365,900.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Frank Anders Wilson sold 37,535 shares of the company’s stock in a transaction on Thursday, December 7th. The stock was sold at an average price of $70.14, for a total transaction of $2,632,704.90. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 73,656 shares of company stock valued at $5,201,957. 2.20% of the stock is owned by insiders.
TRADEMARK VIOLATION NOTICE: “PerkinElmer (PKI) Earns Media Impact Rating of 0.26” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright law. The original version of this story can be viewed at https://www.dispatchtribunal.com/2017/12/09/perkinelmer-pki-earns-media-impact-rating-of-0-26.html.
PerkinElmer Company Profile
PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.
Receive News & Ratings for PerkinElmer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer Inc. and related companies with MarketBeat.com's FREE daily email newsletter.